Latest Cancer News

Longest Follow-Up to Date Shows Active Surveillance is Safe and Feasible (04-23-2014)
Results from the longest follow-up to date of active surveillance in patients with favorable or intermediate-risk prostate cancer indicate that the approach is safe and feasible for as long as 20 years... Continue Reading

Xtandi Shows Significant Benefit in Chemotherapy-Naïve, Metastatic, Hormone-Refractory Prostate Cancer (04-21-2014)
Xtandi® (enzalutamide) showed significant survival benefit in men with chemotherapy-naïve, metastatic, hormone-refractory prostate cancer, according to the results of a study presented at the 2014 European... Continue Reading

Viagra Associated with Increased Risk of Melanoma (04-18-2014)
Men who take by Viagra (sildenafil) are 84 percent more likely to develop melanoma than men who do not, according to the results of a study published in JAMA Internal Medicine. Melanoma is a potentially... Continue Reading

More Cancer News

Events

Tower Oncology’s Cancer Support Network Brings New Services to West Side
Organizations partner to offer full range of cancer support and education to meet a growing need. Read more…


Tower Hematology Oncology Medical Group Named Fight Back Chair For American Cancer Society’s Relay for Life Event in Beverly Hills
Cancer treatment center seeks volunteers, donations for April 30 cancer support fundraiser
Read more…

Tower News

Tower Hematology Oncology Medical Group has been awarded a three-year term of accreditation in computed tomography (CT) and positron emission tomography (PET) as the result of a recent review by the American College of Radiology (ACR). CT scanning — sometimes called CAT scanning — is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. Learn more…

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map